The British pharmaceutical company GlaxoSmithKleine (GSK) has announced plans to supply the expensive rotavirus vaccine, used for prevention of severe diarrhoea in children, at cost price.
GSK chief executive Andrew Witty outlines the company's new "standards".
Get in touch with Today via
email
,
Twitter
or
Facebook
or text us on 84844.
Bookmark with:
What are these?
E-mail this to a friend